Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

For Amanda Merriman, the pin she received as she completed CCCC’s nursing program represented every late night, every ...

C4 Therapeutics, Inc. ( NASDAQ:CCCC ) defied analyst predictions to release its first-quarter results, which were ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Investors are always looking for stocks that are poised to beat at earnings season and C4 Therapeutics, Inc. CCCC, may be one such company. The firm has earnings coming up pretty soon, and events are ...

Investors might want to bet on C4 Therapeutics, Inc. (CCCC), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

C4 Therapeutics, Inc. (CCCC) has been on a downward spiral lately with significant selling pressure. After declining 26.2% over the past four weeks, the stock looks well positioned for a trend ...